Jr. Michael Conick Hanley - Jun 8, 2022 Form 4 Insider Report for Aeglea BioTherapeutics, Inc. (AGLE)

Role
Chief Commercial Officer
Signature
/s/ James Kastenmayer, by power of attorney
Stock symbol
AGLE
Transactions as of
Jun 8, 2022
Transactions value $
$20,022
Form type
4
Date filed
6/10/2022, 06:24 PM
Previous filing
Feb 22, 2022
Next filing
Aug 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGLE Common Stock Purchase $20K +28.2K +352.5% $0.71 36.2K Jun 8, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 8,000 shares of common stock acquired by the Reporting Person pursuant to the Issuer's employee stock purchase plan.